Eli Lilly Executive Compensation Details Revealed

Ticker: LLY · Form: DEF 14A · Filed: 2025-03-21T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, DEF-14A, annual-filing

Related Tickers: LLY

TL;DR

LLY's 2025 DEF 14A shows exec pay details for FY24, including pension and equity awards.

AI Summary

Eli Lilly and Company (LLY) filed its DEF 14A on March 21, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on aggregated changes in pension values and retirement benefits, as well as equity awards granted and outstanding. Specific dollar amounts and dates related to these compensation elements are provided for the fiscal years 2024, 2023, and 2022.

Why It Matters

This filing provides transparency into how Eli Lilly compensates its top executives, which can influence investor perception and corporate governance.

Risk Assessment

Risk Level: low — This is a routine annual filing disclosing executive compensation and does not present new material risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this DEF 14A filing?

The primary purpose of this DEF 14A filing is to provide detailed information regarding Eli Lilly and Company's executive compensation for the fiscal year ending December 31, 2024.

When was this DEF 14A filed with the SEC?

This DEF 14A filing was filed with the SEC on March 21, 2025.

What specific compensation elements are detailed in the filing?

The filing details elements such as aggregated changes in pension values, retirement benefits, and equity awards granted and outstanding for the covered fiscal years.

For which fiscal years does the filing provide compensation data?

The filing provides compensation data for the fiscal years ending December 31, 2024, 2023, and 2022.

What is Eli Lilly and Company's Central Index Key (CIK)?

Eli Lilly and Company's Central Index Key (CIK) is 0000059478.

From the Filing

0000059478-25-000107.txt : 20250321 0000059478-25-000107.hdr.sgml : 20250321 20250321161052 ACCESSION NUMBER: 0000059478-25-000107 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 113 CONFORMED PERIOD OF REPORT: 20250321 FILED AS OF DATE: 20250321 DATE AS OF CHANGE: 20250321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELI LILLY & Co CENTRAL INDEX KEY: 0000059478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 350470950 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-06351 FILM NUMBER: 25760594 BUSINESS ADDRESS: STREET 1: LILLY CORPORATE CTR STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 BUSINESS PHONE: 3172762000 MAIL ADDRESS: STREET 1: LILLY CORPORATE CENTER STREET 2: DROP CODE 1094 CITY: INDIANAPOLIS STATE: IN ZIP: 46285 FORMER COMPANY: FORMER CONFORMED NAME: LILLY ELI & CO DATE OF NAME CHANGE: 19941024 DEF 14A 1 lly-20250321.htm DEF 14A lly-20250321 0000059478 DEF 14A FALSE iso4217:USD iso4217:USD xbrli:shares 0000059478 2024-01-01 2024-12-31 0000059478 2023-01-01 2023-12-31 0000059478 2022-01-01 2022-12-31 0000059478 2021-01-01 2021-12-31 0000059478 2020-01-01 2020-12-31 0000059478 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 lly:AdjustmentChangeInValueUnvestedEquityMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 lly:AdjustmentFinalValueVestedEquityMember ecd:PeoMember 2024-01-01 2024-12-31 0000059478 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 lly:AdjustmentChangeInValueUnvestedEquityMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 lly:AdjustmentFinalValueVestedEquityMember ecd:PeoMember 2023-01-01 2023-12-31 0000059478 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 lly:AdjustmentChangeInValueUnvestedEquityMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 lly:AdjustmentFinalValueVestedEquityMember ecd:PeoMember 2022-01-01 2022-12-31 0000059478 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 lly:AdjustmentChangeInValueUnvestedEquityMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 lly:AdjustmentFinalValueVestedEquityMember ecd:PeoMember 2021-01-01 2021-12-31 0000059478 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2020-01-01 2020-12-31 0000059478 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2020-01-01 2020-12-31 0000059478 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2020-01-01 2020-12-31 0000059478 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2020-01-01 2020-12-31 0000059478 lly:AdjustmentChangeInValueUnvestedEquityMember ecd:PeoMember 2020-01-01 2020-12-31

View on Read The Filing